@misc{indiciae155822d8dd4f,
  title = {TP53 mutations in endometrial cancer contribute to clinically-relevant radiation resistance and highlight the potential for biomarker-driven radiosensitization strategies.},
  author = {Vargas, R. and Petty, A. and Yard, B. and Durmaz, A. and Lin-Rahardja, K. and Scott, J.},
  year = {2022},
  doi = {10.1101/2022.09.06.505009},
  url = {https://www.biorxiv.org/content/10.1101/2022.09.06.505009v1},
  note = {Source identifier: 10.1101/2022.09.06.505009}
}